Clinical Trials on Myopic Macular Degeneration in Mexico

Total 938 results

Asociación para Evitar la Ceguera en México

Unknown

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Cystoid Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Bevacizumab and Retinal Vascular Occlusions

Vascular Occlusion | Edema Macular

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation (NEPAF)

Macular Edema | Macular Thickening

Mexico
Asociación para Evitar la Ceguera en México

Completed

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Allegro Ophthalmics, LLC

Withdrawn

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

POSTERIOR SUB-TENON'S Avastin

Diffuse Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Diffuse Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular Degeneration | Choroidal Neovascularization

Mexico
Progen Pharmaceuticals

Completed

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Age Related Macular Degeneration

United States, Mexico, Russian Federation
Laboratorios Sophia S.A de C.V.

Recruiting

Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema (PRO-169)

Diabetic Macular Edema

Colombia, Mexico
Asociación para Evitar la Ceguera en México

Completed

Avastin for Post-Photocoagulation Macular Edema

Macular Edema

Mexico
Oraya Therapeutics, Inc.

Unknown

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | Wet Age-Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
Hospital Juarez de Mexico

Unknown

Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Contrast Sensitivity and Diabetic Macular Edema

DIABETES MELLITUS | DIABETIC RETINOPATHY | MACULAR EDEMA

Mexico
NuVasive

Completed

Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)

Degenerative Disc Disease

United States
Asociación para Evitar la Ceguera en México

Unknown

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

* Diffuse Diabetic Macular Edema

Mexico
Bayer

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease

Mexico
Asociación para Evitar la Ceguera en México

Completed

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Bayer

Completed

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (AQUILA)

Macular Degeneration

Mexico, Argentina, Colombia, Costa Rica
National Polytechnic Institute, Mexico
Hospital Infantil de Mexico Federico Gomez; Instituto de Oftalmología Fundación...

Completed

Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis

Childhood Atopic Dermatitis

Mexico
AbbVie

Completed

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | Wet Age-related Macular Degeneration

United States
Instituto Nacional de Psiquiatría Dr. Ramón de...

Completed

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Second Generation Antipsychotic Induced Metabolic Adverse Effects

Mexico
Hospital Juarez de Mexico

Completed

Diabetic Macular Edema Severity at Diagnosis

Diabetes Mellitus | Diabetic Retinopathy | Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy

Macular Edema | Proliferative Diabetic Retinopathy

Mexico
Hospital Juarez de Mexico

Completed

Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema

Diabetic Retinopathy | Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Visual Function, Center Point Thickness and Macular Volume After Photocoagulation

Diabetic Retinopathy | Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema

Diabetic Retinopathy | Clinically Significant Macular Edema

Mexico
Rush Eye Associates

Completed

ILM Peeling in PDR Patients Undergoing PPV for VH

Diabetic Retinopathy | Macular Edema

Mexico
Rush Eye Associates

Completed

PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME

Diabetic Retinopathy | Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetic Macular Edema | Diabetes Mellitus Type 2

Mexico
PanOptica, Inc.

Completed

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Neovascular Age-related Macular Degeneration

United States, Czechia, United Kingdom, Hungary, Latvia
Especialistas en Retina Medica y Quirurgica Grupo...
Centro de Retina Medica y Quirurgica S.C.

Completed

MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) (MINIMA-2)

Diabetic Macular Edema

Argentina, Mexico
Carmen Clapp
Universidad Autónoma de Querétaro; Instituto Mexicano de Oftalmologia (IMO); General... and other collaborators

Recruiting

Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
AbbVie
AbbVie

Enrolling by invitation

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Gene Therapy | AMD | nAMD | Wet AMD | Neovascular Age-Related Macular Degeneration (nAMD) | wAMD

United States
VisionCare, Inc.

Recruiting

Telescope Exchange Study (TES)

Age-related Macular Degeneration

United States
AbbVie
AbbVie

Recruiting

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)

Neovascular Age-Related Macular Degeneration (nAMD)

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration (OCTAVE)

Neovascular Age-related Macular Degeneration

Germany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
NuVasive

Completed

An Evaluation of Interlaminar Lumbar Instrumented (ILIF™) (ILIF)

Degenerative Disc Disease

United States
CoMentis

Terminated

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Macular Degeneration

Brazil, Mexico, Czech Republic, Poland, Russian Federation, Ukraine
University of New Mexico

Completed

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

Retinitis Pigmentosa | Age Related Macular Degeneration | Congenital Stationary Night Blindness | Colorblindness

United States
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (AVONELLE-X)

Neovascular Age-related Macular Degeneration

United States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Neovascular Age-related Macular Degeneration

United States, Puerto Rico
Outlook Therapeutics, Inc.

Recruiting

A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Age-Related Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration

United States
Regeneron Pharmaceuticals

Terminated

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD) (CAPELLA)

Neovascular Age-Related Macular Degeneration

United States, Japan
Outlook Therapeutics, Inc.

Completed

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Age-related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein Occlusion

United States

Clinical Trials on Myopic Macular Degeneration in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations